Shira Zelber‐Sagi

2006–2025 年に発表

別表記
Shira Zelber-Sagi
112
論文数
19,481
被引用数
55
h 指数
102
i10 指数

被引用数

Shira Zelber‐Sagi の年別被引用数2001 年: 被引用 3 件2002 年: 被引用 1 件2005 年: 被引用 1 件2006 年: 被引用 4 件2007 年: 被引用 14 件2008 年: 被引用 23 件2009 年: 被引用 20 件2010 年: 被引用 24 件2011 年: 被引用 32 件2012 年: 被引用 45 件2013 年: 被引用 48 件2014 年: 被引用 71 件2015 年: 被引用 65 件2016 年: 被引用 84 件2017 年: 被引用 88 件2018 年: 被引用 83 件2019 年: 被引用 375 件2020 年: 被引用 559 件2021 年: 被引用 884 件2022 年: 被引用 1,101 件2023 年: 被引用 1,109 件2024 年: 被引用 1,849 件2025 年: 被引用 1,285 件2026 年: 被引用 38 件2003〜2004 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図中国: 引用元論文 1,658 件、この内訳の 14.8%アメリカ合衆国: 引用元論文 1,501 件、この内訳の 13.4%イタリア: 引用元論文 747 件、この内訳の 6.7%イギリス: 引用元論文 649 件、この内訳の 5.8%ドイツ: 引用元論文 447 件、この内訳の 4%スペイン: 引用元論文 439 件、この内訳の 3.9%韓国: 引用元論文 331 件、この内訳の 2.9%オーストラリア: 引用元論文 314 件、この内訳の 2.8%フランス: 引用元論文 298 件、この内訳の 2.6%カナダ: 引用元論文 269 件、この内訳の 2.4%日本: 引用元論文 265 件、この内訳の 2.4%インド: 引用元論文 212 件、この内訳の 1.9%
0%14.8%その他 36.4%

分野

  • Medicine88.5%
  • Biochemistry, Genetics and Molecular Biology6.4%
  • Nursing1%
  • Environmental Science0.7%
  • Health Professions0.6%
  • Agricultural and Biological Sciences0.5%
  • その他2.3%

トピック

  • Liver Disease Diagnosis and Treatment26.4%
  • Liver Disease and Transplantation7.9%
  • Diet, Metabolism, and Disease7.4%
  • Diabetes, Cardiovascular Risks, and Lipoproteins4.2%
  • Alcohol Consumption and Health Effects3.9%
  • Diet and metabolism studies3.8%
  • その他46.4%

共著者

全論文

検索で開く
  1. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Vlad Ratziu, Jacob George - Journal of Hepatology 2020 被引用: 4,410

  2. EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)

    著者: , , , , , , , , , , , , , , - Journal of Hepatology 2024 被引用: 1,650

  3. Advancing the global public health agenda for NAFLD: a consensus statement

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yusuf Yılmaz, Zobair M. Younossi, Shira Zelber‐Sagi, Fredrik Åberg, Leon A. Adams, Maryam Salem Al Khatry, Khalid Al Naamani, Omar Alfaro Murillo, Alina M. Allen, Faisal Abdullatif Alnaser, Saleh A. Alqahtani, Khalid Alswat, Domenico Alvaro, Raúl J. Andrade, Marco Arrese, Yaw Asante Awuku, Motala Ayesha, Oidov Baatarkhuu, Shokhista Bakieva, Rita Basu, Ramón Bataller, Shahinaz Bedri, Emanuele Bosi, Marc Bourlière, Radan Brůha, Elisabetta Bugianesi, Patrizia Burra, Marı́a Buti, Christopher D. Byrne, José Luís Calleja, Patrizia Carrieri, Flloyd Carter, Marlén Ivón Castellanos Fernández, Gabriela Castillo-Lopez, Graciela Castro‐Narro, Henry Lik‐Yuen Chan, Wah‐Kheong Chan, Yoosoo Chang, Massimo Colombo, Kirsten J. Coppell, Kathleen E. Corey, Antonio Craxı̀, Donna R. Cryer, Anuradha Supun Dassanayake, Antonieta de Ascenção Soares Martins, Victor de Lédinghen, Stefano DelPrato, Sandro Demaio, Hailemichael Desalegn, John Dillon, Ajay Duseja, Prabhakaran Dorairaj, Mattias Ekstedt, Mohamed El‐Kassas, Osama Mohamed Elsanousi, Gamal Esmat, Jian‐Gao Fan, Nathalie J. Farpour‐Lambert, Robert Flisiak, Yasser Fouad, Michael Fuchs, Rino Alvani Gani, Lynn H. Gerber, Hasmik Ghazinyan, Liana Gheorghe, George Boon‐Bee Goh, Henning Grønbæk, Aghayeva Gulnara, Saeed Hamid, Vanessa Hebditch ほか 121 名 - Nature Reviews Gastroenterology & Hepatology 2021 被引用: 736

  4. Treatment of NAFLD with diet, physical activity and exercise

    著者: , , - Journal of Hepatology 2017 被引用: 1,319

  5. The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alison Taylor, Tim Rhodes, Carla Treloar, Claus Petersen, Christoph Schramm, Robert Flisiak, Marieta Y Simonova, Albert Pares, Philip Johnson, Alessandro Cucchetti, Isabel Graupera, Christos Lionis, Elisa Pose, Núria Fabrellas, Ann T Ma, Juan M Mendive, Vincenzo Mazzaferro, Harry Rutter, Helena Cortez-Pinto, Deirdre Kelly, Robyn Burton, Jeffrey V Lazarus, Pere Ginès, Maria Buti, Philip N Newsome, Patrizia Burra, Michael P Manns - The Lancet 2021 被引用: 627

  6. Lifestyle interventions in nonalcoholic fatty liver disease

    著者: , , , - Nature Reviews Gastroenterology & Hepatology 2023 被引用: 258

  7. EASL Clinical Practice Guidelines on nutrition in chronic liver disease

    著者: , , , , , , , - Journal of Hepatology 2018 被引用: 1,055

  8. doi:https://doi.org/10.1016/j.jhep.2021.10.025

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - 2021 被引用: 261

  9. Administrative Coding in Electronic Health Care Record‐Based Research of NAFLD: An Expert Panel Consensus Statement

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Hepatology 2021 被引用: 246

  10. Non-alcoholic fatty liver disease: A patient guideline

    著者: , , , , , , , , , , , , , , , , , , - JHEP Reports 2021 被引用: 256

  11. openalex_id:w4200584065

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alison Taylor, Tim Rhodes, Carla Treloar, Claus Petersen, Christoph Schramm, Robert Flisiak, Marieta Simonova, Albert Parés, Philip J. Johnson, Alessandro Cucchetti, Isabel Graupera, Christos Lionis, Elisa Pose, Núria Fabrellas, Ann T., Juan Manuel Mendive, Vincenzo Mazzaferro, Harry Rutter, Helena Cortez‐Pinto, Déirdre Kelly, Robyn Burton, Jeffrey V. Lazarus, Pere Ginès, Marı́a Buti, Philip N. Newsome, Patrizia Burra, Michael P. Manns 被引用: 245

  12. Current therapies and new developments in NASH

    著者: , , , , , , , , - Gut 2022 被引用: 196

  13. Global multi-stakeholder endorsement of the MAFLD definition

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Manuel Romero‐Gomez, Mohammed Eslam, Maria Lorena Abate, Bahaa Abbas, Ahmed Amr Abbassy, Waleed Abd El Ghany, Amira Abd Elkhalek, Emad Abd ElMajeed, Mohammad Abdalgaber, Mohamed AbdAllah, Marwa Abdallah, Nourhan Abdallah, Shereen Abdelaleem, Yasser Abdelghani, Wael Abdelghany, Safaa Mohamed Abdelhalim, Wafaa Abdelhamid, Nehal Abdelhamid, Nadia A. Abdelkader, Elsayed Abdelkreem, Aly Mohamed Abdelmohsen, Awny Ali Abdelrahman, Sherief M Abd-elsalam, Doaa Abdeltawab, Abdulbaset Abduh, Nada Abdulhakam, Maheeba Abdulla, Navid Abedpoor, Ludovico Abenavoli, Fredrik Åberg, Omala Ablack, Mostafa Abo elftouh, Yousry Esam-Eldin Abo-Amer, Ashraf Aboubkr, Alaa Aboud, Amr M. Abouelnaga, Galal A. Aboufarrag, Ashraf Aboutaleb, Leticia Abundis, Gupse Adalı, Enrique Adames, Leon Adams, Danjuma Adda, Noor Adel, Nada Adel, Muhammad Adel Sayed, Taiba Jibril Afaa, Nawal Afredj, Gulnara Aghayeva, Alessio Aghemo, Carlos A. Aguilar-Salinas, Golo Ahlenstiel, Walid Ahmady, Wafaa Ahmed, Amira Ahmed, Samah Nasser Ahmed, Heba Mostafa Ahmed, Rasha Ahmed, Elmar Aigner, Mesut Akarsu, Maisam Akroush, Umit Akyuz, Mamun Al Mahtab, Tahani Al Qadiri, Yusriya Al Rawahi, Razzaq AL rubaee, Muna Al Saffar, Shahinul Alam, Zaid Al-Ani, Agustín Albillos ほか 957 名 - ˜The œLancet. Gastroenterology & hepatology 2022 被引用: 223

  14. Effects of personalized diets by prediction of glycemic responses on glycemic control and metabolic health in newly diagnosed T2DM: a randomized dietary intervention pilot trial

    著者: , , , , , , , , , , , , , , - BMC Medicine 2022 被引用: 140

  15. A global research priority agenda to advance public health responses to fatty liver disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Shiv Kumar Sarin, Marcelo Silva, C Wendy Spearman, Emmanuel Tsochatzis, Luca Valenti, Marcela Villota‐Rivas, Shira Zelber‐Sagi, Jörn M. Schattenberg, Vincent Wai‐Sun Wong, Zobair M. Younossi, Jeffrey V. Lazarus, Henry E. Mark, Alina M. Allen, Juan Pablo Arab, Patrizia Carrieri, Mazen Noureddin, William Alazawi, Naim Alkhouri, Saleh A. Alqahtani, Marco Arrese, Ramón Bataller, Thomas Berg, Paul Brennan, Patrizia Burra, Graciela Castro‐Narro, Helena Cortez‐Pinto, Kenneth Cusi, Nikos Dedes, Ajay Duseja, Sven Francque, Hannes Hagström, Terry T.‐K. Huang, Dana Ivancovsky‐Wajcman, Achim Kautz, Christopher J. Kopka, Aleksander Krag, Veronica Miller, Philip N. Newsome, Mary E. Rinella, Diana Romero, Shiv Kumar Sarin, Marcelo Silva, C. Wendy Spearman, Emmanuel Tsochatzis, Luca Valenti, Marcela Villota‐Rivas, Shira Zelber‐Sagi, Jörn M. Schattenberg, Vincent Wai‐Sun Wong, Zobair M. Younossi, Fredrik Åberg, Leon A. Adams, Khalid Al‐Naamani, Reda Albadawy, Zinaida Alexa, Michael Allison, Faisal Abdullatif Alnaser, Khalid Alswat, Mário Reis Álvares‐da‐Silva, Domenico Alvaro, Michele Alves‐Bezerra, Raúl J. Andrade, Quentin M. Anstee, Yaw Asante Awuku, Oidov Baatarkhuu, György Baffy, Shokhista Bakieva, Meena B. Bansal, Robert Barouki, Rachel L. Batterham ほか 241 名 - Journal of Hepatology 2023 被引用: 132

  16. Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marcelo Silva, Mary E. Rinella, Ashwani K. Singal, Stuart C. Gordon, Michael Fuchs, Naim Alkhouri, Kenneth Cusi, Rohit Loomba, Jane Ranagan, Wayne Eskridge, Achim Kautz, Janus P. Ong, Marcelo Kugelmas, Yuichiro Eguchi, M. Diago, Ming‐Lung Yu, Lynn H. Gerber, Lisa Fornaresio, Fatema Nader, Linda Henry, Andrei Racila, Pegah Golabi, Maria Stepanova, Patrizia Carrieri, Jeffrey V. Lazarus - Journal of Hepatology 2023 被引用: 96

  17. A global action agenda for turning the tide on fatty liver disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Diana Romero, Shiv Kumar Sarin, Marcelo Silva, C Wendy Spearman, Norah A. Terrault, Emmanuel Tsochatzis, Luca Valenti, Marcela Villota‐Rivas, Shira Zelber‐Sagi, Jörn M. Schattenberg, Vincent Wai‐Sun Wong, Zobair M. Younossi, on behalf of the Healthy Livers, Healthy Lives Collaborators - Hepatology 2023 被引用: 90

  18. High red and processed meat consumption is associated with non-alcoholic fatty liver disease and insulin resistance

    著者: , , , , , , - Journal of Hepatology 2018 被引用: 298

  19. The Mediterranean dietary pattern as the diet of choice for non‐alcoholic fatty liver disease: Evidence and plausible mechanisms

    著者: , , - Liver International 2017 被引用: 263

  20. EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD): Executive Summary

    著者: , , , , , , , , , , , , , , - Diabetologia 2024 被引用: 156

  21. Defining comprehensive models of care for NAFLD

    著者: , , , , , , , , , , , , - Nature Reviews Gastroenterology & Hepatology 2021 被引用: 148

  22. Association of Nonalcoholic Fatty Liver Disease With Lower Brain Volume in Healthy Middle-aged Adults in the Framingham Study

    著者: , , , , , , , , - JAMA Neurology 2017 被引用: 183

  23. The future of International Classification of Diseases coding in steatotic liver disease: An expert panel Delphi consensus statement

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jeffrey V. Lazarus - Hepatology Communications 2024 被引用: 43

  24. Diet Associations With Nonalcoholic Fatty Liver Disease in an Ethnically Diverse Population: The Multiethnic Cohort

    著者: , , , , , , , - Hepatology 2019 被引用: 146